MYGN
#2835
Myriad Genetics, Inc. - Common Stock
6.2 8 USD
+0.04%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+3.97%
Variación mensual
+45.71%
Variación en los últimos 6 meses
+3.97%
Cambio anual
-24.06%
Cierres anteriores
6.0 4
Open
6.1 8
Mínimo
6.1 8
High
6.3 2
Volumen
227
Financials
- Market Capitalization 593.13 M
- Employee 2 700
- Founded 1991
- CEO Paul J. DiazPaul J. Diaz
- Website www.myriad.com
- Headquarter Delaware, United States
- FIGI BBG000D9H9F1
- Industry Diagnóstico y pruebas
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.56
Relación precio/flujo de caja
0.69
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2696 |  CSTL Castle Biosciences, Inc. - Common stock | 23.41 USD | +1.25% | 0.00% | +13.04% | -4.90% | 710.02 M USD | ||
| 2832 |  FLGT Fulgent Genetics, Inc. - Common Stock | 20.88 USD | +2.05% | +0.72% | +14.73% | -11.64% | 593.01 M USD | ||
| 3197 |  PRE Prenetics Global Limited - Class A Ordinary Share | 18.70 USD | -11.96% | +15.57% | -10.95% | +123.95% | 315.55 M USD | ||
| 3261 |  LAB Standard BioTools Inc. - Common Stock | 0.86 USD | +2.38% | +2.38% | +2.38% | -28.93% | 335.46 M USD |